NCT01721161 arm group 6f8ce038bc50a5372fcaf86e4b300bb6 [clinicaltrials_resource:NCT01721161/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01721161 arm group 6f8ce038bc50a5372fcaf86e4b300bb6 [clinicaltrials_resource:NCT01721161/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6]
Bio2RDF identifier
NCT01721161/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 8ce038bc50a5372fcaf86e4b300bb6
description [clinicaltrials_vocabulary:description]
Participants will receive Plac ...... 20 weeks (a total of 6 doses).
identifier
clinicaltrials_resource:NCT01721161/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6
title
NCT01721161 arm group 6f8ce038bc50a5372fcaf86e4b300bb6
@en
type
label
NCT01721161 arm group 6f8ce038 ...... ce038bc50a5372fcaf86e4b300bb6]
@en